• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p16ink4对生长的抑制作用需要功能性视网膜母细胞瘤蛋白。

Growth suppression by p16ink4 requires functional retinoblastoma protein.

作者信息

Medema R H, Herrera R E, Lam F, Weinberg R A

机构信息

Whitehead Institute for Biomedical Research, Nine Cambridge Center, MA 02142, USA.

出版信息

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6289-93. doi: 10.1073/pnas.92.14.6289.

DOI:10.1073/pnas.92.14.6289
PMID:7603984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC41503/
Abstract

p16ink4 has been implicated as a tumor suppressor that is lost from a variety of human tumors and human cell lines. p16ink4 specifically binds and inhibits the cyclin-dependent kinases 4 and 6. In vitro, these kinases can phosphorylate the product of the retinoblastoma tumor suppressor gene. Thus, p16ink4 could exert its function as tumor suppressor through inhibition of phosphorylation and functional inactivation of the retinoblastoma protein. Here we show that overexpression of p16ink4 in certain cell types will lead to an arrest in the G1 phase of the cell cycle. In addition, we show that p16ink4 can only suppress the growth of human cells that contain functional pRB. Moreover, we have compared the effect of p16ink4 expression on embryo fibroblasts from wild-type and RB homozygous mutant mice. Wild-type embryo fibroblasts are inhibited by p16ink4, whereas the RB nullizygous fibroblasts are not. These data not only show that the presence of pRB is crucial for growth suppression by p16ink4 but also indicate that the pRB is the critical target acted upon by cyclin D-dependent kinases in the G1 phase of the cell cycle.

摘要

p16ink4被认为是一种肿瘤抑制因子,在多种人类肿瘤和人类细胞系中缺失。p16ink4特异性结合并抑制细胞周期蛋白依赖性激酶4和6。在体外,这些激酶可磷酸化视网膜母细胞瘤肿瘤抑制基因的产物。因此,p16ink4可能通过抑制视网膜母细胞瘤蛋白的磷酸化和功能失活来发挥其肿瘤抑制功能。在此我们表明,在某些细胞类型中过表达p16ink4会导致细胞周期在G1期停滞。此外,我们表明p16ink4只能抑制含有功能性pRB的人类细胞的生长。而且,我们比较了p16ink4表达对野生型和RB纯合突变小鼠胚胎成纤维细胞的影响。野生型胚胎成纤维细胞受到p16ink4的抑制,而RB纯合缺失的成纤维细胞则不受影响。这些数据不仅表明pRB的存在对p16ink4的生长抑制作用至关重要,还表明pRB是细胞周期G1期细胞周期蛋白D依赖性激酶作用的关键靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eee/41503/9333b0a39872/pnas01490-0086-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eee/41503/a2f9fe3d8856/pnas01490-0084-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eee/41503/4b738009dadb/pnas01490-0086-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eee/41503/9333b0a39872/pnas01490-0086-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eee/41503/a2f9fe3d8856/pnas01490-0084-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eee/41503/4b738009dadb/pnas01490-0086-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eee/41503/9333b0a39872/pnas01490-0086-b.jpg

相似文献

1
Growth suppression by p16ink4 requires functional retinoblastoma protein.p16ink4对生长的抑制作用需要功能性视网膜母细胞瘤蛋白。
Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6289-93. doi: 10.1073/pnas.92.14.6289.
2
Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.p18是一种与p16INK4/MTS1及p14INK4B/MTS2相关的细胞周期蛋白依赖性激酶6(CDK6)抑制剂,其对生长的抑制作用与野生型视网膜母细胞瘤蛋白(pRb)的功能相关。
Genes Dev. 1994 Dec 15;8(24):2939-52. doi: 10.1101/gad.8.24.2939.
3
PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.PTEN肿瘤抑制因子通过视网膜母细胞瘤蛋白与细胞周期调控相关联。
Oncogene. 1999 Dec 9;18(52):7462-8. doi: 10.1038/sj.onc.1203151.
4
Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.细胞周期蛋白D1对E2F转录因子的激活作用被p16INK4阻断,p16INK4是假定的肿瘤抑制基因MTS1的产物。
Oncogene. 1994 Dec;9(12):3475-82.
5
p16INK4 mediates contact-inhibition of growth.p16INK4介导生长的接触抑制。
Oncogene. 1999 Jan 7;18(1):277-81. doi: 10.1038/sj.onc.1202270.
6
Mutations and altered expression of p16INK4 in human cancer.人类癌症中p16INK4的突变与表达改变
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11045-9. doi: 10.1073/pnas.91.23.11045.
7
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.Rb阴性细胞中细胞周期蛋白D-Cdk复合物的缺失与高水平的p16INK4/MTS1肿瘤抑制基因产物相关。
EMBO J. 1995 Feb 1;14(3):503-11. doi: 10.1002/j.1460-2075.1995.tb07026.x.
8
Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.六亚甲基双乙酰胺在TM2H小鼠上皮细胞中抑制细胞生长期间视网膜母细胞瘤蛋白与D型细胞周期蛋白的相互作用
Mol Carcinog. 1998 Jun;22(2):128-43.
9
Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.人细胞系中含p16INK4和p18复合物的生化特性
J Biol Chem. 1996 Jul 5;271(27):15942-9. doi: 10.1074/jbc.271.27.15942.
10
Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines.p16Ink4和视网膜母细胞瘤抑癌基因的畸变出现在人类癌细胞系的不同亚组中。
Int J Cancer. 1995 Mar 29;61(1):115-20. doi: 10.1002/ijc.2910610120.

引用本文的文献

1
Cerebrovascular p16 expression induces cerebral small vessel disease-related phenotypes.脑血管p16表达诱导脑小血管病相关表型。
Acta Neuropathol Commun. 2025 Aug 12;13(1):171. doi: 10.1186/s40478-025-02085-x.
2
Deciphering the differential impact of CDK4 mutations on abemaciclib binding in oral squamous cell carcinoma: a precision medicine approach.解读CDK4突变对口腔鳞状细胞癌中阿贝西利结合的差异影响:一种精准医学方法。
Ir J Med Sci. 2025 Jul 21. doi: 10.1007/s11845-025-03994-5.
3
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).

本文引用的文献

1
Mammalian G1 cyclins.哺乳动物G1期细胞周期蛋白。
Cell. 1993 Jun 18;73(6):1059-65. doi: 10.1016/0092-8674(93)90636-5.
2
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.细胞周期蛋白D与视网膜母细胞瘤基因产物(pRb)的直接结合以及细胞周期蛋白D依赖性激酶CDK4对pRb的磷酸化作用。
Genes Dev. 1993 Mar;7(3):331-42. doi: 10.1101/gad.7.3.331.
3
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.视网膜母细胞瘤蛋白相关蛋白p107对细胞增殖的抑制作用。
帕博西尼在 cyclinD-cdk4/6-INK4a-Rb 通路中存在基因组改变的实体瘤患者中的应用:来自美国国家癌症研究所-儿童肿瘤组儿科分子分析用于治疗选择试验 I 臂(APEC1621I)的结果。
JCO Precis Oncol. 2024 Sep;8:e2400418. doi: 10.1200/PO-24-00418.
4
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.从隐窝到癌症:结直肠癌发生和治疗策略的整体观点。
Int J Mol Sci. 2024 Aug 30;25(17):9463. doi: 10.3390/ijms25179463.
5
Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance.CDK4/6抑制剂与其他疗法联合的策略及耐药机制。
Int J Clin Exp Pathol. 2024 Jul 15;17(7):189-207. doi: 10.62347/HGNI4903. eCollection 2024.
6
Sodium valproate affects the expression of p16 and p21 cyclin‑dependent kinase inhibitors in HeLa cells.丙戊酸钠影响HeLa细胞中p16和p21细胞周期蛋白依赖性激酶抑制剂的表达。
Oncol Lett. 2024 Jul 11;28(3):432. doi: 10.3892/ol.2024.14563. eCollection 2024 Sep.
7
ASCL2 is a key regulator of the proliferation-differentiation equilibrium in the esophageal epithelium.ASCL2 是食管上皮细胞增殖-分化平衡的关键调节因子。
Biol Open. 2024 Jan 15;13(1). doi: 10.1242/bio.059919. Epub 2024 Jan 22.
8
SNIP1 and PRC2 coordinate cell fates of neural progenitors during brain development.SNIP1 和 PRC2 在大脑发育过程中协调神经祖细胞的命运。
Nat Commun. 2023 Aug 8;14(1):4754. doi: 10.1038/s41467-023-40487-4.
9
Cellular senescence and neurodegeneration.细胞衰老与神经退行性变。
Hum Genet. 2023 Aug;142(8):1247-1262. doi: 10.1007/s00439-023-02565-x. Epub 2023 Apr 28.
10
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges.CDK4/6抑制剂在胰胆管癌中的应用:机遇与挑战
Cancers (Basel). 2023 Feb 3;15(3):968. doi: 10.3390/cancers15030968.
Genes Dev. 1993 Jul;7(7A):1111-25. doi: 10.1101/gad.7.7a.1111.
4
Function of a human cyclin gene as an oncogene.一种人类细胞周期蛋白基因作为癌基因的功能。
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):709-13. doi: 10.1073/pnas.91.2.709.
5
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.相关的20K调节亚基在体内对细胞周期蛋白依赖性激酶2(CDK2)活性的抑制作用。
Nature. 1993 Dec 16;366(6456):707-10. doi: 10.1038/366707a0.
6
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.细胞周期调控中的一种新调控基序,可特异性抑制细胞周期蛋白D/细胞周期蛋白依赖性激酶4。
Nature. 1993 Dec 16;366(6456):704-7. doi: 10.1038/366704a0.
7
p21 is a universal inhibitor of cyclin kinases.p21是细胞周期蛋白激酶的通用抑制剂。
Nature. 1993 Dec 16;366(6456):701-4. doi: 10.1038/366701a0.
8
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.p21 Cdk相互作用蛋白Cip1是G1期细胞周期蛋白依赖性激酶的有效抑制剂。
Cell. 1993 Nov 19;75(4):805-16. doi: 10.1016/0092-8674(93)90499-g.
9
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.人肉瘤中CDK4基因与MDM2和GLI的共扩增。
Cancer Res. 1993 Nov 15;53(22):5535-41.
10
Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.在缺乏功能性视网膜母细胞瘤蛋白的细胞中,细胞周期蛋白D/细胞周期蛋白依赖性激酶复合物缺失。
Oncogene. 1994 Jun;9(6):1633-40.